THERE are a lot more factors to consider when it comes to the regression of our immune system than previously thought.

During the 66th American Society of Hematology Annual Meeting and Exposition, investigators revealed early-phase 1 data evaluating various BTK degraders that leverage different strategies to overcome ...

The U.S. FDA has provided advice for Tiakis Biotech's Phase 2 clinical trial of tiprelestat for pulmonary arterial ...

High blood pressure, or hypertension, is a global health concern affecting millions of individuals across diverse ...